Skip Navigation

A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.

We deliver transformative solutions that power real results. See how we can help.

Optimizing Supply Chain
Integrating Pharmacy
Maximizing Value-Based Care
Awards and Recognition

Transforming healthcare is more than our objective, it’s in our DNA. We’re dedicated to ensuring better health is just the beginning.


Guided by our values, our employees work every day to make meaningful differences in healthcare. At the core of what we do is our most valuable resource - our people. Learn more about us.

Board of Directors
Speakers Bureau

Premier is more than a GPO. Combining robust analytics with consulting and advocacy, we’re changing the healthcare landscape for the better.

Collective purchasing power lowers costs across your organization.

Intelligence plus unparalleled analytics equals data-driven solutions.

It’s only impossible until it’s not. Premier and our team of experts are transforming care delivery.

Work with Premier members to lower costs, improve quality and safety and succeed in value-based care.

A voice for better healthcare policy is a voice for you.

Working closely with our members, we’re developing products and services to solve your most complex challenges.

Lower costs, greater efficiencies and a healthier bottom line.

Proven practices that result in better outcomes.

Intersecting specialty drugs with better management and data-driven best practices.

Controlling your future with integrated care delivery practices.

More savings and ROI is a win-win.

Data diving to deliver insights you can act on.

Supporting healthcare transformation through the generation of real-world evidence.

Working closely with our members, we're developing products and services to solve your most complex challenges.

Discover what leading healthcare providers are achieving through Premier membership.

Stay informed with our white papers, webinars and e-books.

Browse our blog for a taste of what’s new and what’s next in healthcare.

Premier’s perspectives have been solicited by nationally renowned publications. Read on.

Read Premier’s latest announcements.

Catch our policy statements and perspectives on the latest in DC.

Compelling stories from the front lines of America’s health systems.

The proactive, predictive and behind-the-scenes insights you need to stay ahead in healthcare delivered monthly to your inbox.

A Look Inside Exela's Domestic Pharmaceutical Manufacturing Facility

Watch our new video to see how Premier, Exela® Pharma Sciences and Premier members are protecting the future of the pharmaceutical supply chain together.

Today, the Premier team, member health systems, community leaders and U.S. Senator Ted Budd (R-NC) visited Exela® Pharma Sciences’ Lenoir, NC headquarters and state-of-the-art manufacturing facility.

The facility tour allowed visitors to see first-hand how Premier, Exela and Premier members are working together to boost sustainable domestic manufacturing, help prevent and alleviate drug shortages and enhance supply chain resiliency for critical pharmaceuticals.

One of the most critical lessons we learned during the pandemic is that when we outsource too much of our manufacturing capabilities overseas, we create vulnerabilities here at home.

This overreliance led to widespread shortages for critical medical products and drugs during the pandemic. And it continues to put us at the mercy of future events – including natural disasters, disease outbreaks or geopolitical events.

This is why it’s so important to invest in domestic and diverse sources.

Concrete solutions that prevent and resolve drug shortages, and support greater domestic production, must decrease manufacturer barriers to entry – namely the time and cost to enter the marketplace.

Premier and our members’ investment in Exela (and other domestic producers) provide up-front liquidity, aggregated demand and buying commitments that take away the guessing game for manufacturers to give the surety needed to expand production, invest in redundancies, modernize facilities and drive innovations for sustainable resiliency.

The Exela investment:

  • Gives providers access to 20+ high-quality, U.S.-made pharmaceutical products and safety stock.
  • Includes several generic injectables that frequently appear on the U.S. Food and Drug Administration (FDA) drug shortage list, as well as 503B pharmaceutical products made by Exela.
  • Gave Exela much-needed capital to invest in domestic production and drive innovations to bolster supply.

3 out of 4 healthcare and supply chain leaders say domestic manufacturing is an “extremely” or “very important” component to their organizations’ supply chain resiliency strategies, according to Premier’s recent survey.

With strong supplier relationships and armed with robust data and input from our valued members, Premier remains committed to building on these strong partnerships to:

  • Create more domestic options;
  • Support job creation for local economies; and
  • Build partnerships to mitigate supply chain risks, product shortages and disruptions.

Together, we’re taking action and developing collaborative solutions to build healthier pharmaceutical markets and supply chains for providers, patients and communities.

Login Register Change Registration